The struggling genetic-testing 23andMe is looking for a buyer for the virtual-care business it acquired in 2021, Business ...

Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to ...

Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...

Lemonaid's service covers conditions like urinary tract infections (UTIs), birth control, acne, hair loss, hypothyroidism, erectile dysfunction, sexually-transmitted diseases, and insomnia ...

Buying prescription drugs online is easier than ever. But there are side effects. Direct-to-consumer startups like Hims and Ro want you to bypass your doctor and buy prescription drugs directly ...

The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts.